These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 18539035)

  • 1. Discovery of potent CCR4 antagonists: Synthesis and structure-activity relationship study of 2,4-diaminoquinazolines.
    Yokoyama K; Ishikawa N; Igarashi S; Kawano N; Hattori K; Miyazaki T; Ogino S; Matsumoto Y; Takeuchi M; Ohta M
    Bioorg Med Chem; 2008 Jul; 16(14):7021-32. PubMed ID: 18539035
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Potent CCR4 antagonists: synthesis, evaluation, and docking study of 2,4-diaminoquinazolines.
    Yokoyama K; Ishikawa N; Igarashi S; Kawano N; Masuda N; Hattori K; Miyazaki T; Ogino S; Orita M; Matsumoto Y; Takeuchi M; Ohta M
    Bioorg Med Chem; 2008 Sep; 16(17):7968-74. PubMed ID: 18694645
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Potent and orally bioavailable CCR4 antagonists: Synthesis and structure-activity relationship study of 2-aminoquinazolines.
    Yokoyama K; Ishikawa N; Igarashi S; Kawano N; Masuda N; Hamaguchi W; Yamasaki S; Koganemaru Y; Hattori K; Miyazaki T; Ogino S; Matsumoto Y; Takeuchi M; Ohta M
    Bioorg Med Chem; 2009 Jan; 17(1):64-73. PubMed ID: 19081254
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Discovery and SAR of trisubstituted thiazolidinones as CCR4 antagonists.
    Allen S; Newhouse B; Anderson AS; Fauber B; Allen A; Chantry D; Eberhardt C; Odingo J; Burgess LE
    Bioorg Med Chem Lett; 2004 Apr; 14(7):1619-24. PubMed ID: 15026036
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Core exploration in optimization of chemokine receptor CCR4 antagonists.
    Purandare AV; Wan H; Somerville JE; Burke C; Vaccaro W; Yang X; McIntyre KW; Poss MA
    Bioorg Med Chem Lett; 2007 Feb; 17(3):679-82. PubMed ID: 17098428
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The synthesis of substituted bipiperidine amide compounds as CCR3 ligands: antagonists versus agonists.
    Ting PC; Umland SP; Aslanian R; Cao J; Garlisi CG; Huang Y; Jakway J; Liu Z; Shah H; Tian F; Wan Y; Shih NY
    Bioorg Med Chem Lett; 2005 Jun; 15(12):3020-3. PubMed ID: 15908209
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Discovery and optimization of novel 3-piperazinylcoumarin antagonist of chemokine-like factor 1 with oral antiasthma activity in mice.
    Li G; Wang D; Sun M; Li G; Hu J; Zhang Y; Yuan Y; Ji H; Chen N; Liu G
    J Med Chem; 2010 Feb; 53(4):1741-54. PubMed ID: 20099827
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification and optimization of novel 2-(4-oxo-2-aryl-quinazolin-3(4H)-yl)acetamide vasopressin V3 (V1b) receptor antagonists.
    Letourneau JJ; Riviello CM; Li H; Cole AG; Ho KK; Zanetakos HA; Desai H; Zhao J; Auld DS; Napier SE; Thomson FJ; Goan KA; Morphy JR; Ohlmeyer MH; Webb ML
    Bioorg Med Chem Lett; 2010 Sep; 20(18):5394-7. PubMed ID: 20719508
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Discovery of N-(4-methoxyphenyl)-N,2-dimethylquinazolin-4-amine, a potent apoptosis inducer and efficacious anticancer agent with high blood brain barrier penetration.
    Sirisoma N; Pervin A; Zhang H; Jiang S; Willardsen JA; Anderson MB; Mather G; Pleiman CM; Kasibhatla S; Tseng B; Drewe J; Cai SX
    J Med Chem; 2009 Apr; 52(8):2341-51. PubMed ID: 19296653
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Discovery of 2-chloro-N-(4-methoxyphenyl)-N-methylquinazolin-4-amine (EP128265, MPI-0441138) as a potent inducer of apoptosis with high in vivo activity.
    Sirisoma N; Kasibhatla S; Pervin A; Zhang H; Jiang S; Willardsen JA; Anderson MB; Baichwal V; Mather GG; Jessing K; Hussain R; Hoang K; Pleiman CM; Tseng B; Drewe J; Cai SX
    J Med Chem; 2008 Aug; 51(15):4771-9. PubMed ID: 18651728
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Design, synthesis and SAR study of novel trisubstituted pyrimidine amide derivatives as CCR4 antagonists.
    Xu L; Zhang Y; Dai W; Wang Y; Jiang D; Wang L; Xiao J; Yang X; Li S
    Molecules; 2014 Mar; 19(3):3539-51. PubMed ID: 24662072
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Optimization of CCR4 antagonists: side-chain exploration.
    Purandare AV; Wan H; Gao A; Somerville J; Burke C; Vaccaro W; Yang X; McIntyre KW; Poss MA
    Bioorg Med Chem Lett; 2006 Jan; 16(1):204-7. PubMed ID: 16236499
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Racemic and chiral lactams as potent, selective and functionally active CCR4 antagonists.
    Newhouse B; Allen S; Fauber B; Anderson AS; Eary CT; Hansen JD; Schiro J; Gaudino JJ; Laird E; Chantry D; Eberhardt C; Burgess LE
    Bioorg Med Chem Lett; 2004 Nov; 14(22):5537-42. PubMed ID: 15482919
    [TBL] [Abstract][Full Text] [Related]  

  • 14. 2,8-Diazaspiro[4.5]decan-8-yl)pyrimidin-4-amine potent CCR4 antagonists capable of inducing receptor endocytosis.
    Shukla L; Ajram LA; Begg M; Evans B; Graves RH; Hodgson ST; Lynn SM; Miah AH; Percy JM; Procopiou PA; Richards SA; Slack RJ
    Eur J Med Chem; 2016 Jun; 115():14-25. PubMed ID: 26991939
    [TBL] [Abstract][Full Text] [Related]  

  • 15. RS-1748, a novel CC chemokine receptor 4 antagonist, inhibits ovalbumin-induced airway inflammation in guinea pigs.
    Nakagami Y; Kawase Y; Yonekubo K; Nosaka E; Etori M; Takahashi S; Takagi N; Fukuda T; Kuribayashi T; Nara F; Yamashita M
    Biol Pharm Bull; 2010; 33(6):1067-9. PubMed ID: 20522980
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lead optimization of 4-(dimethylamino)quinazolines, potent and selective antagonists for the melanin-concentrating hormone receptor 1.
    Kanuma K; Omodera K; Nishiguchi M; Funakoshi T; Chaki S; Semple G; Tran TA; Kramer B; Hsu D; Casper M; Thomsen B; Sekiguchi Y
    Bioorg Med Chem Lett; 2005 Sep; 15(17):3853-6. PubMed ID: 16002290
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Guanidine and 2-aminoimidazoline aromatic derivatives as alpha2-adrenoceptor ligands: searching for structure-activity relationships.
    Rodriguez F; Rozas I; Ortega JE; Erdozain AM; Meana JJ; Callado LF
    J Med Chem; 2009 Feb; 52(3):601-9. PubMed ID: 19133776
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bipiperidinyl carboxylic acid amides as potent, selective, and functionally active CCR4 antagonists.
    Kuhn CF; Bazin M; Philippe L; Zhang J; Tylaska L; Miret J; Bauer PH
    Chem Biol Drug Des; 2007 Sep; 70(3):268-72. PubMed ID: 17718722
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Discovery of 4-(dimethylamino)quinazolines as potent and selective antagonists for the melanin-concentrating hormone receptor 1.
    Kanuma K; Omodera K; Nishiguchi M; Funakoshi T; Chaki S; Semple G; Tran TA; Kramer B; Hsu D; Casper M; Thomsen B; Beeley N; Sekiguchi Y
    Bioorg Med Chem Lett; 2005 May; 15(10):2565-9. PubMed ID: 15863317
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Solution phase parallel synthesis of substituted 3-phenylsulfonyl-[1,2,3]triazolo[1,5-a]quinazolines: selective serotonin 5-HT(6) receptor antagonists.
    Ivachtchenko AV; Golovina ES; Kadieva MG; Koryakova AG; Kovalenko SM; Mitkin OD; Okun IM; Ravnyeyko IM; Tkachenko SE; Zaremba OV
    J Comb Chem; 2010 Jul; 12(4):445-52. PubMed ID: 20349953
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.